These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1828580)

  • 1. [Current and future aspects of chondroprotective treatments].
    Bannwarth B; Harmand MF
    Presse Med; 1991 Apr; 20(15):683-5. PubMed ID: 1828580
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cartilage-protective preparations in the therapy of osteoarthrosis].
    Tsvetkova ES; Agababova ER; Bogomolova NA
    Ter Arkh; 1992; 64(5):59-60. PubMed ID: 1455377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AE 941--Neovastat.
    Drugs R D; 1999 Feb; 1(2):135-6. PubMed ID: 10566006
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel drug treatment strategies for osteoarthritis.
    Creamer P; Dieppe PA
    J Rheumatol; 1993 Sep; 20(9):1461-4. PubMed ID: 8164198
    [No Abstract]   [Full Text] [Related]  

  • 5. Is there preliminary in-vivo evidence for an influence of nonsteroidal antiinflammatory drugs on progression in osteoarthritis? Part II-evidence from animal models.
    Serni U; Mannoni A; Benucci M
    Osteoarthritis Cartilage; 1999 May; 7(3):351-2. PubMed ID: 10329329
    [No Abstract]   [Full Text] [Related]  

  • 6. Cartilage degradation: is there a place for chondroprotective agents? A symposium of the American College of Rheumatology. Cincinnati, Ohio, June 17, 1989. Proceedings.
    Semin Arthritis Rheum; 1990 Feb; 19(4 Suppl 1):1-32. PubMed ID: 2315704
    [No Abstract]   [Full Text] [Related]  

  • 7. [Scintigraphic monitoring of chondro-protective therapy of finger polyarthritis].
    Ammer K; Knechtsberger P; Atefie K
    Wien Med Wochenschr; 1990; 140(21):526-30. PubMed ID: 2275207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphokines and cytokines.
    Wagstaff J
    Cancer Chemother Biol Response Modif; 1990; 11():204-34. PubMed ID: 1699586
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphokines and cytokines.
    Wagstaff J; Melief K
    Cancer Chemother Biol Response Modif; 1988; 10():416-33. PubMed ID: 2484321
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential anti-inflammatory and chondroprotective effects of simulated digests of indomethacin and an herbal composite (Mobility) in a cartilage explant model of articular inflammation.
    Pearson W; Orth MW; Lindinger MI
    J Vet Pharmacol Ther; 2007 Dec; 30(6):523-33. PubMed ID: 17991220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Rumalon (glycosaminoglycan-peptide) on the articular tissue.
    Skrivánková B; Julis I; Podrazký V; Trnavský K
    Agents Actions Suppl; 1993; 39():219-24. PubMed ID: 8456632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The present state of chondroprotective therapy in osteoarthrosis].
    Pelísková Z; Trnavský K; Krajícková-Trnavská J
    Acta Chir Orthop Traumatol Cech; 1989 Jun; 56(3):185-9. PubMed ID: 2526987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chondroprotective effect of selective COX-2 inhibition in osteoarthritis: ex vivo evaluation of human cartilage tissue after in vivo treatment.
    de Boer TN; Huisman AM; Polak AA; Niehoff AG; van Rinsum AC; Saris D; Bijlsma JW; Lafeber FJ; Mastbergen SC
    Osteoarthritis Cartilage; 2009 Apr; 17(4):482-8. PubMed ID: 18926729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biochemical studies of potentially antiarthritic drugs].
    Greiling H
    Z Rheumatol; 1983; 42(4):153-8. PubMed ID: 6228079
    [No Abstract]   [Full Text] [Related]  

  • 15. The inhibitory effects of steroidal and non-steroidal antirheumatic drugs on articular cartilage in osteoarthrosis and its counteraction by a biological GAG-peptide complex (Rumalon).
    Kalbhen DA
    Z Rheumatol; 1982; 41(5):202-11. PubMed ID: 7158084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphokines and cytokines.
    Wagstaff J; Melief KJ
    Cancer Chemother Biol Response Modif; 1987; 9():432-53. PubMed ID: 2484327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current aspects of immunomodulatory therapy initiation for sepsis].
    Karzai W; Gramm HJ; Reinhart K
    Dtsch Med Wochenschr; 1998 Jul; 123(31-32):948-52. PubMed ID: 9721572
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term NSAID treatment directly decreases COX-2 and mPGES-1 production in the articular cartilage of patients with osteoarthritis.
    Alvarez-Soria MA; Herrero-Beaumont G; Moreno-Rubio J; Calvo E; Santillana J; Egido J; Largo R
    Osteoarthritis Cartilage; 2008 Dec; 16(12):1484-93. PubMed ID: 18547825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simulated digest of a glucosamine-based equine nutraceutical modifies effect of IL-1 in a cartilage explant model of inflammation.
    Pearson W; Lindinger MI
    J Vet Pharmacol Ther; 2008 Jun; 31(3):268-71. PubMed ID: 18471150
    [No Abstract]   [Full Text] [Related]  

  • 20. [The relation between the level of antibodies to the glycosaminoglycans of the cartilage in patients with osteoarthritis and the efficacy of treatment with chondroprotectors].
    Zavodovskiĭ BV; Kovalenko EA; Fofanova NA; Novikova OV; Zborovskiĭ AB
    Ter Arkh; 1999; 71(5):47-50. PubMed ID: 10399231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.